Mannkind reported $20.06M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Adma Biologics ADMA:US $ 13.24M 965.23K
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biodelivery Sciences International BDSI:US $ 25.78M 1.98M
Chemocentryx CCXI:US $ 19.7M 3.44M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Dynavax Technologies DVAX:US $ 21.08M 862K
Eli Lilly And LLY:US $ 1.58B 107.8M
Flexion Therapeutics FLXN:US $ 27.41M 189K
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Immunogen IMGN:US $ 9.73M 481K
Insmed INSM:US $ 57.18M 5.63M
JAZZ PHA JAZZ:US 429.03M 168.52M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Kindred Biosciences KIN:US 5.87M 1.18M
Macrogenics MGNX:US $ 15.23M 198K
Mannkind MNKD:US $ 20.06M 2.64M
Merk MRK:US $ 2.28B 351M
Minerva Neurosciences NERV:US $ 3.44M 806.44K
Novavax NVAX:US $ 73.16M 9.97M
Novo Nordisk A Fs NVO:US 8.91B 283M
Peregrine Pharmaceuticals PPHM:US $ 4.46M 595K
Pfizer PFE:US $ 2.79B 134M
Xencor XNCR:US $ 8.86M 637K